Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-15 5:14 pm Purchase |
2021-09-13 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 2,945,807 15.700% |
400,554 (+15.74%) |
Filing History |
| 2021-09-07 5:26 pm Purchase |
2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK |
BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% |
1,147,052 (New Position) |
Filing History |
| 2021-07-08 5:00 pm Purchase |
2021-07-06 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 372,617 10.100% |
154,555 (+70.88%) |
Filing History |
| 2021-07-07 4:35 pm Sale |
2021-07-02 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.200% |
-745,500 (-12.84%) |
Filing History |
| 2021-07-06 5:16 pm Purchase |
2021-07-01 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 2,545,253 13.600% |
599,304 (+30.80%) |
Filing History |
| 2021-07-06 5:01 pm Purchase |
2021-06-25 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 2,005,862 7.500% |
2,005,862 (New Position) |
Filing History |
| 2021-05-25 5:22 pm Purchase |
2021-05-21 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 1,945,949 13.000% |
93,438 (+5.04%) |
Filing History |
| 2021-05-17 4:49 pm Purchase |
2021-05-06 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 3,757,049 5.100% |
3,757,049 (New Position) |
Filing History |
| 2021-05-03 5:19 pm Sale |
2021-04-29 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 2,919,471 4.500% |
-2,657,000 (-47.65%) |
Filing History |
| 2021-04-29 4:29 pm Sale |
2021-04-27 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 1,787,559 5.400% |
-1,439,210 (-44.60%) |
Filing History |
| 2021-04-28 09:26 am Purchase |
2021-04-23 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 1,852,511 13.000% |
1,852,511 (New Position) |
Filing History |
| 2021-04-15 4:11 pm Purchase |
2021-04-13 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 6,631,051 10.100% |
2,109,000 (+46.64%) |
Filing History |
| 2021-04-15 4:06 pm Purchase |
2021-04-13 | 13G | ContraFect Corporation CFRX |
BIOTECHNOLOGY VALUE FUND L P | 49,654 10.100% |
13,292 (+36.56%) |
Filing History |
| 2021-04-05 5:03 pm Purchase |
2021-03-26 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 1,599,658 5.100% |
1,599,658 (New Position) |
Filing History |
| 2021-04-02 5:16 pm Sale |
2021-03-31 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 3,530,543 31.400% |
-651,700 (-15.58%) |
Filing History |
| 2021-03-16 5:18 pm Purchase |
2021-03-12 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.100% |
750,207 (+25.24%) |
Filing History |
| 2021-03-15 07:55 am Purchase |
2021-03-10 | 13D | CTI BioPharma Corp. CTIC |
BIOTECHNOLOGY VALUE FUND L P | 17,123,023 19.990% |
4,369,333 (+34.26%) |
Filing History |
| 2021-03-09 9:40 pm Unchanged |
2021-03-08 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 40,819 19.300% |
0 (Unchanged) |
Filing History |
| 2021-03-08 4:54 pm Purchase |
2021-03-04 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 6,338,678 13.800% |
3,200,000 (+101.95%) |
Filing History |
| 2021-03-05 4:33 pm Purchase |
2020-10-14 | 13G | 5:01 Acquisition Corp. FVAM |
BIOTECHNOLOGY VALUE FUND L P | 500,000 5.800% |
500,000 (New Position) |
Filing History |